This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Myriad Genetics, Inc. (MYGN)

NASDAQ

Insider Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Net Insider Transaction 0 45,000 43,261 44,414 49,206 266,074 264,921
Shares Bought 0 55,000 150,000 241,937 423,707 573,836 481,899
Shares Sold 0 10,000 106,739 197,523 374,501 307,762 216,978
Institutional Trading
Historical Data Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago 4 Mo. Ago 5 Mo. Ago 6 Mo. Ago
Total Shares Held 97.26M 96.69M 101.39M 101.39M 98.78M 94.67M 97.62M
Shares Bought 15.72M 15.47M 21.01M 20.99M 16.43M 6.79M 8.41M
Shares Sold 12.53M 12.61M 12.25M 11.71M 11.57M 9.41M 8.52M
MYGN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

MYGN Myriad Genetics, Inc.

Chart of MYGN

Analysts Ratings for MYGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
GET MYGN ANALYST REPORT

MYGN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs